ArticleThe journal of liquid biopsy2026

Clinico-genomic risk stratification for biomarker-enriched trial design in poor-prognosis metastatic castrate-resistant prostate cancer (mCRPC).

Manish Kohli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.